Email UpdatesPolysubstance Use During Pregnancy
The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.
MAT Tools and Resources
The MAT Tools & Resources Collection is a searchable database of tools and resources available to help those who offer or use MAT services. The tools can be filtered by a number of factors, including use, topic, format, audience, and terms of use. Related to the MAT for OUD Environmental scan publications.
Opioid Overdose Crisis Compounded by Polysubstance Use: Fact Sheet
A fact sheet which outlines new strategies that can reduce the risks from polysubstance use.
Opioid Use in the Context of Polysubstance Use: Research Opportunities for Prevention, Treatment, and Sustained Recovery - Executive Summary
A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.
Polysubstance Use Disorders in Four State Medicaid Programs
This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.
Common Comorbidities with Substance Use Disorders Research Report
This research report provides information on the state of the science in the comorbidity of substance use disorders with mental illness and physical health conditions.
Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Practice Guideline for the Treatment of Patients with Substance Use Disorders: Second Edition
A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.
The Telehealth Explainer Series: A Toolkit for State Legislators
This toolkit provides an overview of State telehealth roles, key legislative actions, and a series of briefs exploring opportunities and challenges related to telehealth policy.
Tele-Treatment for Substance Use Disorders
This is a best practice guide about using telehealth for the treatment of substance use disorders, including information about screening, brief intervention, and referral to treatment.
Telehealth Resources for Behavioral Health Clinicians During COVID-19
This document compiles resources and considerations for behavioral health providers treating substance use disorders through use of telehealth during the COVID-19 pandemic.